Hypertrophic cardiomyopathy: Difference between revisions
| Line 72: | Line 72: | ||
| [[Hypertrophic cardiomyopathy surgical treatment#Cardiac transplantation|Selection of Patients for Heart Transplantation]] | | [[Hypertrophic cardiomyopathy surgical treatment#Cardiac transplantation|Selection of Patients for Heart Transplantation]] | ||
*'''Special Clinical Scenarios:''' [[Hypertrophic cardiomyopathy in special clinical scenarios#2011 ACCF/AHA Guideline Recommendations: Patients With LV Systolic Dysfunction (DO NOT EDIT)|Patients With LV Systolic Dysfunction]] | [[Hypertrophic cardiomyopathy risk factors for sudden death#2011 ACCF/AHA Guideline Recommendations: SCD Risk Stratification (DO NOT EDIT) |Sudden cardiac death Risk Stratification]] | [[Hypertrophic cardiomyopathy activities and circumstances to avoid#2011 AHA/ACC Guidelines Recommendations- Participation in Competitive or Recreational Sports and Physical Activity (DO NOT EDIT)|Participation in Competitive or Recreational Sports and Physical Activity]] | [[Hypertrophic cardiomyopathy medical treatment|Management of Atrial Fibrillation]] | [[Hypertrophic cardiomyopathy management during pregnancy|Pregnancy/Delivery]] | [[Hypertrophic cardiomyopathy with coronary artery disease|Concomitant Coronary Disease]] | *'''Special Clinical Scenarios:''' [[Hypertrophic cardiomyopathy in special clinical scenarios#2011 ACCF/AHA Guideline Recommendations: Patients With LV Systolic Dysfunction (DO NOT EDIT)|Patients With LV Systolic Dysfunction]] | [[Hypertrophic cardiomyopathy risk factors for sudden death#2011 ACCF/AHA Guideline Recommendations: SCD Risk Stratification (DO NOT EDIT) |Sudden cardiac death Risk Stratification]] | [[Hypertrophic cardiomyopathy activities and circumstances to avoid#2011 AHA/ACC Guidelines Recommendations- Participation in Competitive or Recreational Sports and Physical Activity (DO NOT EDIT)|Participation in Competitive or Recreational Sports and Physical Activity]] | [[Hypertrophic cardiomyopathy medical treatment#2011 AHA/ACC Guidelines Recommendations- Management of Atrial Fibrillation in HCM (DO NOT EDIT|Management of Atrial Fibrillation]] | [[Hypertrophic cardiomyopathy management during pregnancy|Pregnancy/Delivery]] | [[Hypertrophic cardiomyopathy with coronary artery disease|Concomitant Coronary Disease]] | ||
==Resources== | ==Resources== | ||
Revision as of 20:36, 3 October 2012
For patient information click here
| Hypertrophic cardiomyopathy | |
 | |
|---|---|
| Hypertrophic cardiomyopathy. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | I42.1-I42.2 |
| ICD-9 | 425.4 |
| DiseasesDB | 6373 |
| MeSH | D002312 |
|
Hypertrophic Cardiomyopathy Microchapters |
|
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertrophic cardiomyopathy On the Web |
|
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
|
Risk calculators and risk factors for Hypertrophic cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Hypertrophic cardiomyopathy or HCM, Asymmetric septal hypertrophy or ASH, Hypertrophic obstructive cardiomyopathy, HOCM, Idiopathic hypertrophic subaortic stenosis or IHSS, familial isolated hypertrophic obstructive cardiomyopathy, familial isolated hypertrophic subaortic stenosis, familial or idiopathic hypertrophic subaortic stenosis, familial or idiopathic hypertrophic obstructive cardiomyopathy, primitive hypertrophic obstructive cardiomyopathy, primitive hypertrophic subaortic stenosis, muscular subaortic stenosis, apical hypertrophic cardiomyopathy, which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent)
Overview
Classification
Pathophysiology
Genetics | Histopathologic Abnormalities | Anatomic Abnormalities | Outflow Obstruction | Ischemia | Arrhythmogenesis
Epidemiology and Demographcis
Screening
Differentiating Hypertrophic Cardiomyopathy from other Diseases
Natural History, Prognosis and Sudden Cardiac Death Risk
Diagnosis
History and Symptoms | Physical examination | Electrocardiogram | Echocardiography | Cardiac MRI | Cardiac CT | Positron Emission Tomography
Treatment
- Medical therapy: Supportive Therapy | Pharmacotherapy
- Invasive therapies: Alcohol Septal Ablation | Septal Myectomy | Ventricular Pacing | Automatic Implantable Cardiac Defibrillator (AICD) Placement | Septal Reduction Therapy Guidelines
Special Patient Populations
Asymptomatic Patients | Management During Childhood | Hypotension/Cardiovascular collapse | Pregnancy
2011 ACCF/AHA Guideline Recommendations
Diagnostic testing:
Electrocardiogram | Echocardiography | Stress Testing | Cardiac Magnetic Resonance | Cardiac CT | Positron Emission Tomography
Management:
- Asymptomatic patients: Asymptomatic patients
- Symptomatic patints: Pharmacologic Management
| Invasive Therapies | Alcohol septal ablation | Septal Myectomy | Pacing | Selection of Patients for ICDs | Selection of ICD-Device type | Selection of Patients for Heart Transplantation
- Special Clinical Scenarios: Patients With LV Systolic Dysfunction | Sudden cardiac death Risk Stratification | Participation in Competitive or Recreational Sports and Physical Activity | Management of Atrial Fibrillation | Pregnancy/Delivery | Concomitant Coronary Disease